Drug profile · INN
cefamandole nafate
MANDOL
cefamandole nafate (MANDOL) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefamandole nafate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cefamandole nafate (MANDOL) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefamandole nafate?
cefamandole nafate (MANDOL) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefamandole nafate?
MANDOL is a marketed brand name for cefamandole nafate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefamandole nafate?
cefamandole nafate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.